Landscapes / Companies
Jecho Biopharmaceuticals Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
2 in Phase 1
Drugs
4
in active trials · 6 in all
Trials
6 active
9 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | 12 Feb 2027Phase 1/2 trial completes | |||
| Next date | 12 Feb 2027 · Phase 1/2 trial completes | ||||
| Also tested for | HIV, HIV Infections | ||||
| Open drug page | |||||
— |
Phase 1/2 | Apr 2030Phase 1/2 trial completes | |||
| Next date | Apr 2030 · Phase 1/2 trial completes | ||||
| Also tested for | Recurrent Glioblastoma Multiforme(GBM) | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Mar 2027Phase 1 trial completes | |||
| Next date | 30 Mar 2027 · Phase 1 trial completes | ||||
| Also tested for | High Risk Non-muscle Invasive Bladder Cancer, Malignancies and 3 more | ||||
| Open drug page | |||||
— |
Phase 1 | 14 Mar 2029Phase 1 trial completes | |||
| Next date | 14 Mar 2029 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor (Phase 1), Hodgkin Lymphoma and 1 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021